Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).
Clinical trial NCT00152425 · COMPLETED
Trial details
- NCT number
- NCT00152425
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2005-05-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.